Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Molecular Detection
AddedFeb 15, 2024
UpdatedJun 18, 2026
Molecular Detection

Molecular Detection

Series A

Molecular Detection, Inc.: Global provider of rapid molecular diagnostic tests for infectious diseases.

HQ
Wayne, PA, US
Founded
2007
Overview
Compare
Fundraising
Employees

Molecular Detection, Inc. develops and commercializes molecular diagnostic tests, focusing on rapid detection of infectious diseases such as staph infections. Serving the global healthcare industry, the company aims to enhance diagnostic accuracy and speed, improving patient outcomes.

Molecular Detection has achieved significant milestones in the healthcare sector by providing innovative diagnostic solutions. Their tests are widely recognized for their efficiency and reliability, contributing to better disease management and control worldwide.

Molecular Detection - Similar Companies

Minute Molecular Diagnostics logo

Minute Molecular Diagnostics

Molecular Stethoscope logo

Molecular Stethoscope

DxNA logo

DxNA

MicrobeDx logo

MicrobeDx

microbedx.com

Instadiagnostics logo

Instadiagnostics

NAT Diagnostics logo

NAT Diagnostics

IES Diagnostics logo

IES Diagnostics

Rapid Diagnostek logo

Rapid Diagnostek

PathogenDx logo

PathogenDx

pathogendx.com

Torus Biosystems logo

Torus Biosystems

Specific Diagnostics logo

Specific Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Magnolia Diagnostics logo

Magnolia Diagnostics

PLC Diagnostics logo

PLC Diagnostics

Test Diagnostics logo

Test Diagnostics

Molecular Detection - Quick Facts

Who are Molecular Detection's competitors?

Companies similar to Molecular Detection include Minute Molecular Diagnostics, Molecular Stethoscope, DxNA and MicrobeDx.

When was Molecular Detection founded?

Molecular Detection was founded in 2007.

Where is Molecular Detection's headquarters located?

Molecular Detection's headquarters is located in Wayne, PA, US.

How much has Molecular Detection raised to-date?

As of Dec 1, 2013, Molecular Detection has raised a total of $8.2M (USD).

How many employees does Molecular Detection have?

Molecular Detection has 31 employees as of Feb 5, 2024.

Molecular Detection - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Tests
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research